Metformin, the most commonly used drug to treat type 2 diabetes, not only lowers blood sugar levels but has been revealed to extend lifespan in C. Elegans—an animal model that shares similar metabolic systems with humans and is often used to model human diseases.
promotes longevity by stimulating the body's production of molecules called ether lipids, a major structural component of cell membranes. The findings, which are published in, suggest that boosting production of ether lipids in humans may support healthy aging and reduce the impact of aging-related diseases.
To identify the genes required to enable lifespan extension in response to metformin and its sister drug phenformin , the scientists silenced individual genes in the roundworm Caenorhabditis elegans and examined what happened to the altered worms after exposure to the medications. The experiments reveal that genes that increase production of ether lipids are required to extend lifespan in response to the biguanides. Inactivation of the genes that encode for these enzymes completely prevented the longevity-promoting effects of biguanides. Importantly, inactivation of these genes prevented lifespan extension in a variety of situations that are also known to promote longevity, including dietary restriction.alone was sufficient to extend the lifespan of C.
"Our study implicates promotion of ether lipid biosynthesis as a novel therapeutic target to promote healthy aging. This suggests that dietary or pharmacologic intervention to promote ether lipid synthesis might one day represent a strategy to treat aging and aging-related diseases," says senior author Alexander A. Soukas, MD, Ph.D.
"Because our studies focused solely on interventions in C. elegans, further studies in mammalian models , epidemiological observation, and rigorous clinical trials are required to determine the viability of promoting ether lipid synthesis to promote human health-span and lifespan.
Danmark Seneste Nyt, Danmark Overskrifter
Similar News:Du kan også læse nyheder, der ligner denne, som vi har indsamlet fra andre nyhedskilder.
Osteoarthritis may affect nearly one billion people by 2050, study projectsResearchers analysed 30 years of osteoarthritis data covering more than 200 countries.
Læs mere »
Osteoarthritis may affect nearly one billion people by 2050, study projectsResearchers analysed 30 years of osteoarthritis data covering more than 200 countries.
Læs mere »
Study finds improved prison reentry programs could help flatten rate of opioid overdose deathsWith opioid overdose deaths surging in the United States, many communities are in desperate need of solutions to bring down the body count. Among the most promising is strengthening prison reentry programs for highest-risk users, a Rutgers-led study has found.
Læs mere »
Screening for prostate cancer could help save lives, study suggestsResearchers said current tests are linked to overdiagnosis and overtreatment of low-risk cancer.
Læs mere »
Screening for prostate cancer could help save lives, study suggestsResearchers said current tests are linked to overdiagnosis and overtreatment of low-risk cancer.
Læs mere »
Michael Bloom receives funding to study the impact of PFAS exposure on weight lossMichael Bloom, Associate Professor, Global and Community Health, received $158,900 from the National Institutes of Health for the project: 'Impact of Exposure to Perfluoroalkyl Substances on Weight Loss: A Pilot Study of Hispanic Children with Overweight/Obesity Participating in a Community-based Weight Loss Intervention Program.'
Læs mere »